Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker

Figure 2

In the figure are reported the principal biomarkers evaluated in clinical trials across different tumor types (MM: melanoma, NSCLC: Non-Small Cell Lung Cancer; mCRC: metastatic Colorectal Cancer; BC: Breast Cancer; HN: Head and Neck Cancer; RC: Renal Cancer).